Condition | MotoneuronRheobase(pA) | MotoneuronVm – Vt(mV) | MotoneuronRMP (mV) | MotoneuronRm (MΩ) | InterneuronRheobase(pA) | InterneuronVm – Vt (mV) | InterneuronRMP (mV) | Interneuron Rm (MΩ) |
---|---|---|---|---|---|---|---|---|
Controls in vivo | 81.8 ± 4.3 | 30.3 ± 1.6 | –68.1 ± 1.3 | 599.6 ± 13.8 | 84.1 ± 8.3 | 34.7 ± 2.7 | –70.2 ± 2.2 | 578.5 ± 49.0 |
GABAAR blockers6 h in vivo | 41.7 ± 14.0 | 19.7 ± 3.1 | –62.9 ± 2.5 | 584.3 ± 23.9 | 29.1 ± 5.3 | 21.5 ± 2.1 | –61.1 ± 1.7 | 701.7 ± 57.3 |
GABAAR blockers12 h in vivo | 47.3±5.3 | 26.8 ± 2.9 | –72.7 ± 2.4 | 657.2 ± 67.3 | 20.6 ± 3.7 | 21.1 ± 2.3 | –66.0 ± 2.2 | 624.8 ± 88.1 |
Controls in vitro | 74.3 ± 6.7 | 34.5 ± 2.1 | –68.0 ± 1.4 | 537.2 ± 30.6 | 81.6 ± 5.7 | 33.7 ± 1.8 | –71.3 ± 1.5 | 560.8 ± 40.9 |
GABAAR blockers0–2 h in vitro | 57.8 ± 7.1 | 20.3 ± 1.3 | –59.6 ± 1.8 | 432.3 ± 37.3 | 37.0 ± 6.9 | 16.3 ± 1.4 | –55.6 ± 1.1 | 494.6 ± 58.7 |
GABAAR blockers2–4 h in vitro | 21.8 ± 7.2 | 28.1 ± 1.8 | –58.6 ± 1.8 | 474.4 ± 22.0 | 35.7 ± 7.4 | 21.6 ± 1.4 | –55.4 ± 1.3 | 550.56 ± 70.0 |
GABAAR blockers4–6 h in vitro | 32.1 ± 6.3 | 20.0 ± 1.4 | –60.3 ± 1.1 | 442.0 ± 41.0 | 16.5 ± 2.5 | 15.8 ± 1.5 | –60.3 ± 1.5 | 582.5 ± 109.13 |
GluR blockers0–2 h in vitro | 46.6 ± 10.3 | 18.6 ± 7.2 | –57.4 ± 1.5 | 492.7 ± 76.1 | 34.3 ± 8.7 | 15.8 ± 1.1 | –55.4 ± 1.1 | 555.9 ± 56.4 |
GluR blockers2–4 h in vitro | 27.6 ± 7.4 | 19.1 ± 1.8 | –59.0 ± 1.8 | 704.4 ± 54.3 | 13.7 ± 2.7 | 14.6 ± 1.5 | –53.7 ± 1.1 | 687.1 ± 85.9 |
GluR blockers4–6 h in vitro | 17.7 ± 4.2 | 16.1 ± 1.9 | –58.0 ± 1.5 | 722.5 ± 54.1 | 12.2 ± 4.2 | 14.2 ± 1.1 | –53.7 ± 0.9 | 776.7 ± 72.9 |
Numbers in bold are show significant difference with controls. Measures are averages ± SEs.